Aurora Cannabis Inc. (ACB)

6,70 -0,01 (-0,15%) Börsenschluss: 04:00PM EDT

Aurora Cannabis Inc.

2207 90B Street SW
Edmonton, AB T6X 1V8
Canada

https://www.auroramj.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 1.130

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Miguel Martin	CEO & Director	1,48M	N/A	1973
Mr. Alex Miller	Executive Vice President of Operations & Supply Chain	363,26k	N/A	N/A
Ms. Lori Schick	Executive Vice President of Human Resources	344,57k	N/A	N/A
Mr. Andre Jerome	Executive Vice President of Global Business Development	334,25k	N/A	N/A
Ms. Simona King	Chief Financial Officer	N/A	N/A	1973
Ananth Krishnan	Vice President of Capital Markets & Investor Relations	N/A	N/A	N/A
Ms. Nathalie Clark	Executive VP, General Counsel & Corporate Secretary	N/A	N/A	N/A
Michelle Lefler	Vice President of Communications & Public Relations	N/A	N/A	N/A
Dr. Jonathan Page Ph.D.	Senior Science Advisor	N/A	N/A	1969
Mr. Rick Savone	Senior Vice President of Global Government Relations	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Corporate Governance

Aurora Cannabis Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 7. Die grundlegenden Scores sind Audit: 10, Vorstand: 5, Shareholderrechte: 7, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.